Medication info

Boryung Hemosis Age Solution

Prescription medicationInjection
Ingredient · strength
Sodium Chloride›21.27g / 100mLPotassium Chloride›0.522g / 100mLCalcium Chloride Hydrate›0.772g / 100mLMagnesium Chloride›0.356g / 100mLSodium Acetate Hydrate›1.72g / 100mLGlucose›3.5g / 100mL
Manufacturer / importer
Boryung Pharmaceutical Co., Ltd.
Appearance
A colorless to slightly yellow transparent liquid with a salty taste
Packaging
5.5 liters/container, 10 liters/container
Approval status
Active

MFDS item code 201702678 · Notified 2017.05.29 · Insurance code 641906662,641906663

Summary

Main use
Management of blood glucose in dialysis patients; improvement of electrolyte abnormalities (e.g., hyperkalemia and hypermagnesemia)
Who receives it
Adults
Adult administration
Select an appropriate alkaline solution for artificial kidney dialysis according to the patient's condition and the type of artificial kidney used, and dilute with this solution and purified water before use.

Ingredients

Manufacturer
Boryung Pharmaceutical Co., Ltd.

Efficacy & effects

Management of blood glucose in dialysis patients; improvement of electrolyte abnormalities (e.g., hyperkalemia and hypermagnesemia)

  • Difficulty managing blood glucose levels
  • hyperkalemia
  • hypermagnesemia
  • hypercalcemia
View approved original text

This artificial kidney dialysis perfusion solution is used for patients with chronic renal failure. It is particularly suitable for patients who have difficulty managing blood glucose levels with dialysis solutions that do not contain sugar. In addition, this perfusion liquid is effective when high levels of potassium and magnesium are not adequately improved or if there is a risk of hypercalcemia when using other bicarbonate-based dialysis solutions. Therefore, it helps improve the condition of chronic renal failure patients who have difficulties in managing blood glucose and maintaining electrolyte balance.

How it is given

Adult administration

Select an appropriate alkaline solution for artificial kidney dialysis according to the patient's condition and the type of artificial kidney used, and dilute with this solution and purified water before use.

Precautions

This medication should be used cautiously in patients with severe liver dysfunction or severe diabetes due to abnormalities in acetate metabolism. If acetate is not properly metabolized, cardiac function may be suppressed, and peripheral vessels may dilate, leading to low blood pressure. Furthermore, patients taking digitalis glycosides may experience low serum potassium levels, increasing the risk of digitalis toxicity. During administration of this drug, hypoglycemia and hyperglycemia may occur, so if blood glucose changes are suspected during or after dialysis, appropriate treatment should be administered immediately. If weight gain or increased blood pressure occurs, fluid intake may need to be adjusted or ultrafiltration pressure regulated to remove excess fluid. Due to calcium metabolism disorders, complications such as osteoporosis, osteomalacia, and fibrous osteitis may arise, so measures such as administering active form vitamin D3 or maintaining serum phosphorus within normal ranges are required. Symptoms of dialysis disequilibrium syndrome, such as headache, nausea, vomiting, convulsions, and altered consciousness, may occur, and appropriate measures, including lowering dialysis efficiency, should be taken if these symptoms appear. It may affect the cardiovascular system, and if symptoms of low blood pressure or shock arise, dialysis should be stopped or efficiency reduced, and fluids or vasopressors should be administered. Rarely, increased blood pressure may occur, and administration of antihypertensive agents or changes in dialysis solution may be necessary. This drug is used in hemodialysis for patients with chronic renal failure, particularly when there is a lack of metabolic acidosis improvement or issues such as disequilibrium syndrome or low blood pressure. It is suitable for cases where blood glucose control is difficult with dialysis solutions containing glucose and assists in improving conditions of hyperkalemia or hypermagnesemia due to low potassium, calcium, and magnesium concentrations. Pregnant women or those who may become pregnant should use this drug only when the therapeutic benefits outweigh the risks, as its safety has not been established. Safety has also not been established in pediatrics, so caution is advised. Elderly patients are at risk for bone complications, so regular clinical examinations and administration of active form vitamin D3 as needed are recommended. Only purified water should be used for dialysis dilution, and attention should be paid to potential dialysis membrane damage and bleeding tendencies post-surgery. During preparation, electrolyte solutions for artificial kidney dialysis and bicarbonate solutions should not be used alone but should be prepared with the prescribed dilution. Excessive concentration may lead to side effects such as headaches, blood pressure changes, and altered consciousness. It is important to check the electrolyte concentration and pH of the dialysis solution prior to use, and the mixed solution should be used immediately. The temperature should be adjusted to body temperature for use, and it should not be used for injections or peritoneal dialysis.

Side effects

  • Hypoglycemia
  • hyperglycemia
  • weight gain
  • hypertension
  • osteoporosis
  • osteomalacia
  • fibrous osteitis
  • ectopic calcification
  • headache
  • nausea
Show 15 more
  • vomiting
  • cramps
  • altered consciousness
  • discomfort
  • lethargy
  • hypotension
  • shock symptoms
  • hypertension
  • headache
  • palpitations
  • consciousness disorders
  • limb paralysis sensation
  • general malaise
  • chest discomfort
  • sudden drop in blood pressure

Not everyone experiences these, and they can vary from person to person.

Storage

This drug should be stored in a sealed container to prevent contact with air, ideally at room temperature between 1 degree and 30 degrees. Proper storage will maintain the drug's efficacy and safety.

Appearance and packaging

Appearance

A colorless to slightly yellow transparent liquid with a salty taste

Package unit

5.5 liters/container, 10 liters/container

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.